{"id":1068123,"date":"2021-01-20T01:13:29","date_gmt":"2021-01-20T06:13:29","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/agenus-to-participate-in-b-riley-securities-oncology-investor-conference\/"},"modified":"2024-08-18T11:43:09","modified_gmt":"2024-08-18T15:43:09","slug":"agenus-to-participate-in-b-riley-securities-oncology-investor-conference","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/agenus-to-participate-in-b-riley-securities-oncology-investor-conference.php","title":{"rendered":"Agenus to Participate in B. Riley Securities&#8217; Oncology Investor Conference"},"content":{"rendered":"<p><![CDATA[LEXINGTON, Mass., Jan.  19, 2021  (GLOBE NEWSWIRE) -- Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of checkpoint antibodies, cell therapies, adjuvants, and vaccines designed to activate immune response to cancers and infections, today announced that Dr. Jennifer Buell, President and COO of Agenus, and Dr. Steven O\u2019Day, CMO of Agenus, will participate in B. Riley Securities\u2019 Oncology Investor Conference on January 20-21, 2021.]]><\/p>\n<p>See the rest here:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener\" href=\"http:\/\/www.globenewswire.com\/news-release\/2021\/01\/19\/2160933\/0\/en\/Agenus-to-Participate-in-B-Riley-Securities-Oncology-Investor-Conference.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"Agenus to Participate in B. Riley Securities' Oncology Investor Conference\">Agenus to Participate in B. Riley Securities' Oncology Investor Conference<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>See the rest here: Agenus to Participate in B. Riley Securities' Oncology Investor Conference <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/agenus-to-participate-in-b-riley-securities-oncology-investor-conference.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":64,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-1068123","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1068123"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/64"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=1068123"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1068123\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=1068123"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=1068123"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=1068123"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}